Skip to main content

Find Clinical Trials

Home
Conditions
MET Exon 14 Mutation

Clinical trial condition

MET Exon 14 Mutation

Explore clinical trials studying MET Exon 14 Mutation. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study

Refine in advanced search Browse all conditions

MET Exon 14 Mutation trial results

Recruiting

Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated

NCT06908993

Conditions: Advanced Non Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations: Besançon - CHU Besançon, France

Bordeaux - Institut Bergonie Bordeaux, France

Brest - CHU Brest, France

Caen - CRLCC Caen, France

View all 29 locations

View Trial Details

Not Yet Recruiting

Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung Cancer

NCT07153770

Conditions: MET Activating Mutation, MET Exon 14 Mutation, NSCLC
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant and Adjuvant Targeted Treatment in NSCLC With BRAF V600 or MET Exon 14 Mutations

NCT06054191

Conditions: BRAF V600 Mutation, MET Exon 14 Mutation, NSCLC
Locations: Cancer Center of Sun-Yat Sen University Guangzhou, Guangdong, China

View Trial Details